Literature DB >> 1858644

Thrombocythemia and coronary artery disease.

M G Scheffer1, J J Michiels, M L Simoons, J R Roelandt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1858644     DOI： 10.1016/0002-8703(91)91019-j

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  10 in total

1.  Coronary vasculopathy in polycythemia vera.

Authors:  B Hermanns; S Handt; J Kindler; L Füzesi
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

2.  Familial essential thrombocythemia: clinical characteristics of 11 cases in one family.

Authors:  R J Schlemper; A P van der Maas; J C Eikenboom
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

Review 3.  Primary thrombocythemia: diagnosis, clinical manifestations and management.

Authors:  P J van Genderen; J J Michiels
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673

Review 4.  Disordered haematopoiesis and athero-thrombosis.

Authors:  Andrew J Murphy; Alan R Tall
Journal:  Eur Heart J       Date:  2016-02-10       Impact factor: 29.983

5.  Off-pump myocardial revascularization in a high-risk patient with essential thrombocythemia.

Authors:  Ahmad K Darwazah; Hamad Madi; Rami Zagha; Yahia Hawash
Journal:  Tex Heart Inst J       Date:  2014-10-01

6.  Coronary spasm-related acute myocardial infarction in a patient with essential thrombocythemia.

Authors:  Chi-Wen Cheng; Ming-Jui Hung
Journal:  World J Cardiol       Date:  2011-08-26

Review 7.  Polycythemia and the heart. A review.

Authors:  P Venegoni; G Cyprus
Journal:  Tex Heart Inst J       Date:  1994

Review 8.  Anagrelide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of thrombocythaemia.

Authors:  C M Spencer; R N Brogden
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

9.  Long-term risk of acute coronary syndrome in splenectomized patients due to splenic injury.

Authors:  Ming-Shian Tsai; Sheng-En Chou; Hong-Shiee Lai; Long-Bin Jeng; Cheng-Li Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

Review 10.  Immune-based therapies in cardiovascular and metabolic diseases: past, present and future.

Authors:  Andrew J Murphy; Mark A Febbraio
Journal:  Nat Rev Immunol       Date:  2021-07-20       Impact factor: 53.106
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.